A national recall affecting oils containing CBD and hemp extracts for pets, including chien, was issued on April 1, 2026. This decision has significant implications for pet owners across France, as the recall targets all lots of CBD and hemp-extract oils marketed for cats and dogs under the brands CBDSOL and Mama Kana.
The recall covers products sold between March 18, 2022, and March 19, 2026, prompting consumers to stop using these products immediately. They are instructed to return them to the point of sale or to destroy them. A refund procedure for the recalled products is available until September 1, 2026.
The Ministry of the Economy in France stated that CBD and hemp extracts are unauthorized additives for animal nutrition, emphasizing the need for regulation in this area. “They are regulated and require authorization for their marketing and use,” the Ministry noted.
This recall is part of a broader scrutiny of pet products containing CBD, which have gained popularity in recent years. However, the safety and efficacy of these products for animals remain under question.
In light of this recall, pet owners are urged to be vigilant and informed about the products they use for their pets. The potential health risks associated with unauthorized additives can have serious consequences for animal welfare.
Details remain unconfirmed regarding the specific health impacts of the recalled products. However, the swift action taken by authorities indicates a serious concern over the safety of these items.
As the situation develops, further information is expected from health and regulatory agencies regarding the implications of this recall and any additional measures that may be necessary to ensure pet safety.
In the meantime, consumers are encouraged to seek alternative, approved products for their pets and to stay updated on any new guidelines issued by health authorities.
This recall serves as a reminder of the importance of regulatory oversight in the pet product industry, particularly as new trends, such as the use of CBD, continue to emerge.
As the public awaits further developments, the focus remains on ensuring the safety and well-being of pets across the nation.
